Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

NCT03744806 · clinicaltrials.gov ↗

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Exudative Age-related Macular Degeneration

Interventions

DRUG: Bevacizumab Injection

Sponsor

Medical University of Lublin